Immunotherapy in the Management of Lung Cancer

Immunotherapy in the Management of Lung Cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.

Detaylı Bibliyografya
Yazar:	Tasnim, Humayra
Diğer Yazarlar:	khan, Tanisha Tabassum Sayka
Materyal Türü:	Tez
Dil:	en_US
Baskı/Yayın Bilgisi:	Brac University 2022
Konular:	Lung cancer Immunotherapy Cytokines Checkpoint inhibitors Adoptive cell therapy Vaccines Cancer > Treatment Cancer > Immunotherapy
Online Erişim:	http://hdl.handle.net/10361/17515

Benzer Materyaller

Current practice and approaches of immunotherapy in Cancer treatment
Yazar:: Khondokar, Faiza
Baskı/Yayın Bilgisi: (2022)

A review on targeted therapies for lung cancer
Yazar:: Ashraf, Anushey
Baskı/Yayın Bilgisi: (2023)

Immunotherapy in the treatment of renal cancer
Yazar:: Shimu, Sumaya
Baskı/Yayın Bilgisi: (2022)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
Yazar:: Ratu, Tabassum
Baskı/Yayın Bilgisi: (2024)

Immunotherapeutic approaches to treat cancer: Prospects and challenges
Yazar:: Fred, Namanda Rogers
Baskı/Yayın Bilgisi: (2021)

A review paper on Nanotechnology based strategies in the treatment of cancer
Yazar:: Rahman, Samia
Baskı/Yayın Bilgisi: (2022)

CAR-T cell Therapy in B-cell Lymphoma
Yazar:: Faruk, Asef
Baskı/Yayın Bilgisi: (2020)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Yazar:: Flora, Sanzida Alam
Baskı/Yayın Bilgisi: (2024)

Dendritic cell vaccine for the treatment of cancer
Yazar:: Haque, Tanzila
Baskı/Yayın Bilgisi: (2023)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
Yazar:: Abir, Shifaty Nur
Baskı/Yayın Bilgisi: (2024)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
Yazar:: Bristy, Israt Zerin
Baskı/Yayın Bilgisi: (2021)

Role of toll-like receptors in cancer immunotherapy– a review
Yazar:: Khan, Rezia Nowrin
Baskı/Yayın Bilgisi: (2021)

Stem cell in cancer disease cure vs cause
Yazar:: Chowdhury, Marisha Mansur
Baskı/Yayın Bilgisi: (2023)

RIPK pathway, as a potential target, for cancer treatment - a review
Yazar:: Jahan, Nusrat
Baskı/Yayın Bilgisi: (2024)

Molecules associated with the development of lung cancer
Yazar:: Rahman, Adree, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
Yazar:: Rahman, Sanjida
Baskı/Yayın Bilgisi: (2024)

Potential of liposomes for the treatment of lung cancer- a review
Yazar:: Mim, Shanzida
Baskı/Yayın Bilgisi: (2023)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
Yazar:: Rahman, Tasnim
Baskı/Yayın Bilgisi: (2024)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
Yazar:: Tania, Umme
Baskı/Yayın Bilgisi: (2023)

A review on recent advances in drugs for lung cancer treatment
Yazar:: Noor, Fouzia
Baskı/Yayın Bilgisi: (2024)

Protein biomarkers for Lung Cancer: a bioinformatic approach
Yazar:: Jeba, Joynob
Baskı/Yayın Bilgisi: (2017)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
Yazar:: Razna, Amrin Islam
Baskı/Yayın Bilgisi: (2019)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
Yazar:: Meem, Manila
Baskı/Yayın Bilgisi: (2023)

A review on potential of PARP inhibitors in the treatment of prostate cancer
Yazar:: Islam, Saidul
Baskı/Yayın Bilgisi: (2022)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
Yazar:: Pial, Sazia Afrin
Baskı/Yayın Bilgisi: (2018)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
Yazar:: Paul, Pulock
Baskı/Yayın Bilgisi: (2024)

Stem cells as therapeutic carrier in cancer treatment
Yazar:: Anika, Mysha Yeasmin
Baskı/Yayın Bilgisi: (2022)

Recent advances in Cancer treatment targeting autophagy and future aspects
Yazar:: Emon, Kamrul Hasan
Baskı/Yayın Bilgisi: (2022)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
Yazar:: Shabnam, Musharrat
Baskı/Yayın Bilgisi: (2018)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
Yazar:: Zangmo, Thinley
Baskı/Yayın Bilgisi: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
Yazar:: Hoque, Ismoth Ara
Baskı/Yayın Bilgisi: (2024)

A comprehensive review on drug repurposing in cancer treatment
Yazar:: Sarkar, Onusree
Baskı/Yayın Bilgisi: (2024)

Lung cancer detection and classification using machine learning
Yazar:: Arefin, Mahbubul, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
Yazar:: Nandy, Aditi
Baskı/Yayın Bilgisi: (2022)

Targeted therapeutic options in the treatment of Breast Cancer
Yazar:: Alam, Kazi Tasnuva
Baskı/Yayın Bilgisi: (2022)

Molecular biology of cancer : mechanisms, targets, and therapeutics /
Yazar:: Pecorino, Lauren
Baskı/Yayın Bilgisi: (2012)

Statistics and informatics in molecular cancer research

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
Yazar:: Khan, Muidul Hasan
Baskı/Yayın Bilgisi: (2024)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
Yazar:: Kamal, Tasnova
Baskı/Yayın Bilgisi: (2019)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
Yazar:: Hasan, Amit
Baskı/Yayın Bilgisi: (2024)